Page last updated: 2024-08-24

atorvastatin and thromboxane a2

atorvastatin has been researched along with thromboxane a2 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fuset, MP; Moscardó, A; Ruano, M; Santos, MT; Valles, J	1
Latorre, A; Madrid, I; Moscardó, A; Santos, MT; Vallés, J	1
Dubois, L; Frisbee, JC; Frisbee, SJ; Lemaster, KA; Lewis, MT; Tzemos, N; Wiseman, RW; Wu, F	1

Trials

1 trial(s) available for atorvastatin and thromboxane a2

Article	Year
Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction. The American journal of cardiology, 2009, Dec-15, Volume: 104, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atorvastatin; Blood Platelets; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrroles; Thromboxane A2; Treatment Outcome	2009

Article

Year

Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.

The American journal of cardiology, 2009, Dec-15, Volume: 104, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atorvastatin; Blood Platelets; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrroles; Thromboxane A2; Treatment Outcome

2009

Other Studies

2 other study(ies) available for atorvastatin and thromboxane a2

Article	Year
Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms. Thrombosis research, 2013, Volume: 131, Issue:4 Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Blood Platelets; Calcium; Collagen; Cyclooxygenase 1; Drug Combinations; Drug Synergism; Heptanoic Acids; Humans; Mitogen-Activated Protein Kinases; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylation; Platelet Aggregation; Pravastatin; Pyrroles; Simvastatin; Thromboxane A2; Thromboxane-A Synthase	2013
Chronic atorvastatin and exercise can partially reverse established skeletal muscle microvasculopathy in metabolic syndrome. American journal of physiology. Heart and circulatory physiology, 2018, 10-01, Volume: 315, Issue:4 Topics: Animals; Atorvastatin; Biomarkers; Disease Models, Animal; Epoprostenol; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Microcirculation; Microvessels; Models, Cardiovascular; Muscle, Skeletal; Nitric Oxide; Oxygen Consumption; Peripheral Vascular Diseases; Physical Conditioning, Animal; Physical Exertion; Rats, Zucker; Regional Blood Flow; Running; Thromboxane A2; Time Factors	2018

Article

Year

Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.

Thrombosis research, 2013, Volume: 131, Issue:4

Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Blood Platelets; Calcium; Collagen; Cyclooxygenase 1; Drug Combinations; Drug Synergism; Heptanoic Acids; Humans; Mitogen-Activated Protein Kinases; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylation; Platelet Aggregation; Pravastatin; Pyrroles; Simvastatin; Thromboxane A2; Thromboxane-A Synthase

2013

Chronic atorvastatin and exercise can partially reverse established skeletal muscle microvasculopathy in metabolic syndrome.

American journal of physiology. Heart and circulatory physiology, 2018, 10-01, Volume: 315, Issue:4

Topics: Animals; Atorvastatin; Biomarkers; Disease Models, Animal; Epoprostenol; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Microcirculation; Microvessels; Models, Cardiovascular; Muscle, Skeletal; Nitric Oxide; Oxygen Consumption; Peripheral Vascular Diseases; Physical Conditioning, Animal; Physical Exertion; Rats, Zucker; Regional Blood Flow; Running; Thromboxane A2; Time Factors

2018